Farallon Capital Management’s Amedisys AMED Stock Holding History

Farallon Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-575,000	Closed	-$56.6M	–	148
2025 Q2	$56.6M	Buy	575,000 +50,000	+10%	+$4.73M	0.26%	53
2025 Q1	$48.6M	Sell	525,000 -275,000	-34%	-$25.4M	0.26%	57
2024 Q4	$72.6M	Sell	800,000 -700,000	-47%	-$64.3M	0.38%	54
2024 Q3	$145M	Buy	1,500,000 +191,500	+15%	+$18.7M	0.79%	49
2024 Q2	$120M	Buy	1,308,500 +300,200	+30%	+$27.9M	0.71%	46
2024 Q1	$92.9M	Buy	1,008,300 +322,300	+47%	+$30.2M	0.55%	46
2023 Q4	$65.2M	Buy	686,000 +262,000	+62%	+$24.5M	0.41%	55
2023 Q3	$39.6M	Buy	+424,000	New	+$39.2M	0.22%	66

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return